trending Market Intelligence /marketintelligence/en/news-insights/trending/xttrscy4bhabsdnivz-n9g2 content esgSubNav
In This List

USANA provides FY'18 EPS guidance

Blog

Using ESG Analysis to Support a Sustainable Future

Video

S&P Capital IQ Pro | Powered by Expert Insights

Blog

Q&A: Streamlining Analytics for TCFD Reporting

Blog

Evergrande and the wider impact: a sentiment analytics based perspective


USANA provides FY'18 EPS guidance

U.S. personal products company USANA Health Sciences Inc. on Feb. 6 provided full-year EPS guidance for the fiscal year ending Dec. 31, 2018, as it released results for the fourth quarter and fiscal year ended Dec. 30, 2017.

USANA expects EPS for the full fiscal 2018 to range between $4.05 and $4.45 and consolidated net sales to increase 6% to 10.8% to between $1.11 billion and $1.16 billion in the 12-month period.

The company said its outlook reflects a positive impact from currency fluctuations, which it estimates will boost net sales by about $34 million during the year, and an operating margin of between 13% and 14%. The guidance is based on a tax rate of about 34% for the year and an annualized diluted share count of 24.2 million.

For the fiscal year ended Dec. 30, 2017 the company's net earnings decreased 37.5% year over year to $62.5 million or $2.53 per diluted share compared to $100 million or $3.99 per diluted share in the same period in 2016. The figure included a one-time, non-cash charge of $30.1 million or $1.22 per diluted share related to the U.S. tax reform.

Excluding the impact of the tax reform and expenses related to the company's internal investigation into its China operations, adjusted fiscal year net earnings came in at $100.3 million or $4.06 per diluted share. Net sales grew 4.1% year over year to about $1.05 billion from $1.01 billion in 2016.

For the fourth quarter also ended Dec. 30, 2017, USANA incurred a net loss of $5.9 million or a loss of 24 cents per share compared to net earnings of $21.9 million or 87 cents per diluted share in the same quarter of 2016. The company's net sales rose 8% year over year to $273.1 from $252.9 million a year earlier.